Cabazitaxel Impresses in Locally Advanced De-Differentiated Liposarcoma
(MedPage Today) -- Progression-free survival (PFS) results with cabazitaxel (Jevtana) in metastatic or inoperable locally advanced de-differentiated liposarcoma (DDLPS) suggest the drug should be studied further in this setting, according to investigators... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - August 19, 2022 Category: Hematology Source Type: news

P53 Antagonist Shows Early Activity in Advanced Liposarcoma
(MedPage Today) -- CHICAGO -- Almost 90% of patients with metastatic liposarcoma achieved disease control with an investigational drug targeting p53 suppression, according to an early study reported at the American Society of Clinical Oncology... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - June 9, 2022 Category: Hematology Source Type: news

Reversal speeds creation of important molecule
(Rice University) A Rice University lab's reverse approach to making halichondrin B is the shortest route to what it referred to as a rather complex and important molecule and the parent compound of eribulin, the latter being used to treat breast cancer and liposarcoma. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 29, 2021 Category: Cancer & Oncology Source Type: news

Leiomyosarcoma vs. Liposarcoma
Title: Leiomyosarcoma vs. LiposarcomaCategory: Diseases and ConditionsCreated: 5/10/2021 12:00:00 AMLast Editorial Review: 5/10/2021 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - May 10, 2021 Category: Cancer & Oncology Source Type: news

Lipoma vs. Liposarcoma
Title: Lipoma vs. LiposarcomaCategory: Diseases and ConditionsCreated: 5/10/2021 12:00:00 AMLast Editorial Review: 5/10/2021 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - May 10, 2021 Category: Cancer & Oncology Source Type: news

GLOBAL Sarcoma Therapy Now Approved for Australian Patients
Globally regarded soft tissue sarcoma therapy has been approved by the Therapeutic Goods Administration for Australian patients YONDELISÒ (trabectedin) demonstrates 45% reduction in risk of disease progression or death versus dacarbazine1 SING... Biopharmaceuticals, Oncology, Regulatory Specialised Therapeutics Asia, YONDELIS, trabectedin, liposarcoma, leiomyosarcom (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 23, 2021 Category: Pharmaceuticals Source Type: news

Is Liposarcoma Fast Growing
? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - April 22, 2021 Category: General Medicine Source Type: news

Can Liposarcoma Be Seen on Ultrasound
? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - April 21, 2021 Category: General Medicine Source Type: news

How Common Is Liposarcoma
? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - April 15, 2021 Category: General Medicine Source Type: news

Is liposarcoma life threatening
Is Liposarcoma Life Threatening? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - April 15, 2021 Category: General Medicine Source Type: news

What Are the Signs and Symptoms of Liposarcoma
? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - April 13, 2021 Category: General Medicine Source Type: news

New test provides fast and accurate diagnosis of liposarcomas
(Elsevier) Researchers have leveraged the latest advances in RNA technology and machine learning methods to develop a gene panel test that allows for highly accurate diagnosis of the most common types of liposarcoma. It quickly and reliably distinguishes benign lipomas from liposarcomas and can be performed in laboratories at a lower cost than current 'gold standard' tests. The new assay is described in The Journal of Molecular Diagnosis, published by Elsevier. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 4, 2021 Category: Cancer & Oncology Source Type: news

De-intensification of Radiotherapy Possible in Rare Liposarcoma De-intensification of Radiotherapy Possible in Rare Liposarcoma
De-intensification of preoperative radiotherapy was as effective as standard RT but was associated with far fewer complications in patients with myxoid liposarcoma.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - November 17, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

NUS researchers uncovers promising cancer target for liposarcoma
(National University of Singapore) A study conducted by a team of researchers from the Cancer Science Institute of Singapore (CSI Singapore) at the National University of Singapore has revealed a close association between liposarcoma (LPS), a type of cancer that develops from fat cells, and the bromodomain and extraterminal (BET) protein family. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 3, 2019 Category: International Medicine & Public Health Source Type: news

Family dynamics: Molecules from the same family have different effects in cancer prognosis
(Hiroshima University) Researchers at Hiroshima University have found that different levels of two molecules of the same family -- TIMP-1 and TIMP-4 -- can influence prognosis of liposarcoma. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 13, 2019 Category: International Medicine & Public Health Source Type: news